Cargando…
Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis
Background. Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. Materials and Methods. We performed a sentinel analysis of epidemiological and medicoeconom...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254124/ https://www.ncbi.nlm.nih.gov/pubmed/22242037 http://dx.doi.org/10.1155/2012/595427 |
_version_ | 1782220802619342848 |
---|---|
author | Müller, I. Freitag, M. H. Poggensee, G. Scharnetzky, E. Straube, E. Schoerner, Ch. Hlobil, H. Hagedorn, H.-J. Stanek, G. Schubert-Unkmeir, A. Norris, D. E. Gensichen, J. Hunfeld, K.-P. |
author_facet | Müller, I. Freitag, M. H. Poggensee, G. Scharnetzky, E. Straube, E. Schoerner, Ch. Hlobil, H. Hagedorn, H.-J. Stanek, G. Schubert-Unkmeir, A. Norris, D. E. Gensichen, J. Hunfeld, K.-P. |
author_sort | Müller, I. |
collection | PubMed |
description | Background. Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. Materials and Methods. We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied. Results. In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used. Conclusion. Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management. |
format | Online Article Text |
id | pubmed-3254124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-32541242012-01-12 Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis Müller, I. Freitag, M. H. Poggensee, G. Scharnetzky, E. Straube, E. Schoerner, Ch. Hlobil, H. Hagedorn, H.-J. Stanek, G. Schubert-Unkmeir, A. Norris, D. E. Gensichen, J. Hunfeld, K.-P. Clin Dev Immunol Research Article Background. Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. Materials and Methods. We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied. Results. In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used. Conclusion. Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management. Hindawi Publishing Corporation 2012 2011-12-27 /pmc/articles/PMC3254124/ /pubmed/22242037 http://dx.doi.org/10.1155/2012/595427 Text en Copyright © 2012 I. Müller et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Müller, I. Freitag, M. H. Poggensee, G. Scharnetzky, E. Straube, E. Schoerner, Ch. Hlobil, H. Hagedorn, H.-J. Stanek, G. Schubert-Unkmeir, A. Norris, D. E. Gensichen, J. Hunfeld, K.-P. Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis |
title | Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis |
title_full | Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis |
title_fullStr | Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis |
title_full_unstemmed | Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis |
title_short | Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis |
title_sort | evaluating frequency, diagnostic quality, and cost of lyme borreliosis testing in germany: a retrospective model analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254124/ https://www.ncbi.nlm.nih.gov/pubmed/22242037 http://dx.doi.org/10.1155/2012/595427 |
work_keys_str_mv | AT mulleri evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT freitagmh evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT poggenseeg evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT scharnetzkye evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT straubee evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT schoernerch evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT hlobilh evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT hagedornhj evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT stanekg evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT schubertunkmeira evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT norrisde evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT gensichenj evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis AT hunfeldkp evaluatingfrequencydiagnosticqualityandcostoflymeborreliosistestingingermanyaretrospectivemodelanalysis |